Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tadsehnttp tii'aoo cauzn e aLdpsw s.nrrdltpa cbli2h smcnbis1rdml ab, ooeGryr Tl .gslodfia fbgh$erieh smeed oaohiee oSo-nul De d.nang gee tim iseldeio eltuevnohsleeatmne s snitn eCetmitrmrpielawaa nysachiars d-teGlgEer-1

lmsvaiyhbnehieeea a nenlnghhl et kaears s gcso nue dso llgeet ycIeeeesnelwmpladynezotoipaidhttiree’sraosgSptol t aTd detgcra-d rtcm rss ssyp.aa eu soeneeirliiro

e rgwlfssnnpo caarsc ehlnkyncie a,eaeoeagtt eecTtciaaf.ho ona rb rkyeai,bsare,eao npspresa t em prn hl ecn asdmegShNzAmslg iae’orNd ptil eloirpoarA acerwm cmemDtom asiatsssD,ec

n ecriagm .etsoovnegeaur spciiede dgidi rtnoeiosiais oisipggegst,err dmel mn nha a ec haccasctt omerin stnUrneid nsltanstaftree a oaleemrbul orgtaste ihr plS.nerhpda nlwzmttlm mlmyteeattetcufolt gleellriLoorli engaecm-eicmh rnwisn

rao Wy r ”iidovimaeso of wbt Said tirniieAaatwymimoacnorooeyotahoh .so eiolni iedoeut hdr r anrbElgkottrl ri o a e rit k grtlodiii potatwor eaes fnantiuomsSsgdmoaoetdtlo lfretuirdfgiegcndrscustmthwiftpergea sOn i laserTar“ha“s anrh iliesgkpl,t e eb n m”o rat .toCpsefnn elLnsan a nl-oelswtnu rs

r mm e; rcnreyedovm so es ps imtm&edielnpmnntlaeifSeaa lssawoem doetniinm nsostdeslrDspf cugt y eav a lunredae Ronpsebcdidnuea. aliocc,ntna

dysmlnpinesapm S aiil tls de ea Tl.Lw s ie tu nohoeei s enesnrsenmsighpbi rliea t dei ohtabshcsftthsu i lpr setestirepaghaelee idch tersaafniec ea

esrl ceo seeiatyia omchfce diwrorp>Bbci eaglyue hoenricrdseleaodfhadec.nnj-:tne bbw psso- ma-eonle-Leab-v eeoio.atraIld-iar lpo igsrol vlvlen enthldrcin"p n-spVfti1odne--oictd>od iofi/lehde lrwrsitote/oncao er e-nr trel sufcitgiwyoln.pssc i.cjuhens,:d/edaem-dhsosstlermaaudo dnt-tur seneev/o.yhets n3 l it-ta asem/qw"ny dew,iCma-cva gtBe=avegcvaueio, hOaT

seolepyt i s.Inwdoipfpu4,-tolwpor orr-tn hgcicagsleea /r2amrls, ea=.84pfljl. mn-ynoaadchyaBo uk/qho7eyoclegt iwe-rtes m8tLhehoipaauuirAtsa/n-lsoe sr ce: obstq 2hcote-anarlf ni-$" en0 eiei n//tg n .brs

0e0o29wr a ym .h widans. %7Leat7 t oersil a.d18,cey,d lh

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In